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Abstract 
A transmission experiment involving 5-week-old specific-pathogen-free (SPF) piglets, with (MDA+) or without 
maternally-derived antibodies (MDA−), was carried out to evaluate the impact of passive immunity on the transmis-
sion of a swine influenza A virus (swIAV). In each group (MDA+/MDA−), 2 seeders were placed with 4 piglets in direct 
contact and 5 in indirect contact (3 replicates per group). Serological kinetics (ELISA) and individual viral shedding (RT-
PCR) were monitored for 28 days after infection. MDA waning was estimated using a nonlinear mixed-effects model 
and survival analysis. Differential transmission rates were estimated depending on the piglets’ initial serological status 
and contact structure (direct contact with pen-mates or indirect airborne contact). The time to MDA waning was 71.3 
[52.8–92.1] days on average. The airborne transmission rate was 1.41 [0.64–2.63] per day. The compared shedding 
pattern between groups showed that MDA+ piglets had mainly a reduced susceptibility to infection compared to 
MDA− piglets. The resulting reproduction number estimated in MDA+ piglets (5.8 [1.4–18.9]), although 3 times lower 
than in MDA− piglets (14.8 [6.4–27.1]), was significantly higher than 1. Such an efficient and extended spread of swIAV 
at the population scale in the presence of MDAs could contribute to swIAV persistence on farms, given the fact that 
the period when transmission is expected to be impacted by the presence of MDAs can last up to 10 weeks.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Swine influenza A viruses (swIAVs) cause infections 
responsible for outbreaks of acute respiratory disease 
in pigs worldwide [1–3] with a huge morbidity in swine 
operations [4] and major economic consequences [5, 6] 
due to growth retardation and complicated bacterial or 
viral pulmonary troubles [4, 7, 8].
Swine influenza A viruses are polymorphic enveloped 
single-stranded RNA viruses from the Orthomyxoviri-
dae family [4]. The main causative viruses affecting swine 
production worldwide are H1N1, H1N2 and H3N2 sub-
types, which contain genetic components derived from 
both avian and human influenza viruses leading to dif-
ferent lineages according to their geographical location 
[9–11]. SwIAVs are shed mainly in respiratory secretions. 
The general routes of transmission include pig-to-pig 
contact with infectious pigs, exposure to aerosols or con-
taminated fomites [12]. However, the contribution of air-
borne spread on short distance on virus spread within a 
population has not been quantified to date.
In its classical form, swine flu is known to be respon-
sible for sporadic infections in swine herds, temporarily 
affecting a huge proportion of the pig population within 
an infected herd. However, potential persistence between 
epidemic phases has been increasingly documented in 
European farrow-to-finish herds [13–16]. This endemic 
form of swine flu, currently representing up to 40% of 
the reported cases in France [17], occurs mainly after 
weaning (21 or 28 days of age), affecting piglets of similar 
ages in successive batches and favouring constant health 
disorders on farms. Longitudinal studies have also high-
lighted the possibility for a piglet to experience simulta-
neous or consecutive infections by multiple subtypes [15, 
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16]. This concomitant exposure to different swIAVs can 
favour genome reassortment, leading to the emergence of 
novel reassortant viruses potentially more pathogenic for 
pigs. Public health concerns should also be carefully con-
sidered as illustrated by previous pandemic infections, as 
swIAVs have a zoonotic potential [18].
Several experimental studies were developed to assess 
the transmission of swIAVs in vaccinated piglets or pig-
lets with passively acquired antibodies resulting from sow 
vaccination. In 2011, Romagosa et  al. [19] showed that 
vaccination of animals challenged with a homologous 
influenza virus strain of the American triple reassortant 
H1N1 lineage completely prevents transmission, whereas 
only partial protection was observed with heterologous 
challenge strains. Vaccination was also less effective in 
pigs challenged with a heterologous H3N2 virus [20] 
compared to homologous challenged piglets [21]. Besides 
the impact of their own vaccination, the serological status 
of piglets at birth is presumed to be of primary impor-
tance regarding the spread of influenza among growing 
pigs. Generally, breeding sows are vaccinated on swine 
farms at each reproduction cycle [17, 22] to prevent 
adverse consequences of swIAV infections on reproduc-
tive performance. As a result of this regular vaccination 
of breeding sows, maternally-derived antibodies (MDAs) 
are transferred to a vast majority of piglets. However, the 
role of passive immunity in piglets’ early life is contro-
versial [23]. MDAs provide newborn animals with tem-
porary partial protection from infection, but interference 
between MDAs and post-infectious humoral response 
was documented as early as 1975 [24]. In addition, a fol-
low-up study carried out in permanently-infected herds 
revealed that MDA-positive piglets born to routinely-
vaccinated dams and affected by an early infection had 
an impaired post-infectious humoral response [15]. This 
phenomenon could increase the likelihood of a second 
swIAV infection [25]. In experimental conditions, pre-
vious studies involving strains from American lineages 
suggested that homologous MDAs derived from vaccina-
tion with the same strain as the one used for challenge 
restrained swIAV transmission [26]. Conversely, piglets 
with heterologous MDAs (vaccine and challenge strain 
from different lineages) did not show any significant pro-
tection against infection [26, 27]. Other experimental 
studies have confirmed that MDA-positive piglets are 
not fully protected, restricting the benefit of MDAs to the 
reduction of clinical signs only [21, 25, 28].
A unique trivalent inactivated virus vaccine is licensed 
on European market. It includes three antigens with 
HA genes belonging to three different viral lineages 
commonly identified among the swIAVs circulating in 
European pigs [10, 11, 29]. Quantitative data on epidemi-
ological parameters associated with swIAV infections in 
the presence of passive immunity in the EU context (dif-
ferent vaccine and challenge strains but from the same 
lineage) are pivotal to understand the within-herd swIAV 
endemic feature with systematic infections at similar age 
in successive batches. Such data could further be used to 
identify the determinants of swine flu persistence within 
farrow-to-finish pig herds.
The so-called “protective” effect of MDAs can gather 
different characteristics including reduced susceptibility 
to infection and/or reduced shedding in case of infection. 
The aim of this study was therefore to clarify the impact 
of MDAs on the dynamics of infection in young piglets 
both in terms of transmission (direct and indirect) and 
duration, by quantifying and comparing swIAV spread 
in piglets in the presence and absence of MDAs under 
experimental conditions. For that purpose, individual 
susceptibility to infection and shedding pattern were also 
investigated to identify the mechanisms explaining the 
transmission dynamics observed in a population com-
posed of piglets with and without MDAs. Transmission 
parameters were then estimated according to the contact 
structure between piglets, including the airborne trans-
mission route, and the initial statuses of piglets regarding 
the levels of MDAs.
Materials and methods
Animals
A transmission experiment was conducted in the ANSES 
level 3 biosecurity facilities using specific-pathogen-free 
(SPF) piglets produced in these same facilities. Those 
SPF pigs have a high health status and beside of being 
free from major diseases (Classical swine fever, African 
swine fever, Aujeszky disease, porcine epidemic diar-
rhea virus, transmissible gastro enteritis virus), they are 
also free from numerous endemic viruses such as porcine 
reproductive and respiratory syndrome virus, swIAVs, 
porcine circovirus type 2, porcine parvovirus and bacte-
ria: Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, 
Actinobacillus pleuropneumoniae, Pasteurella multocida, 
Bordetella bronchiseptica, Streptococcus suis 2, and Hae-
mophilus parasuis.
SPF dams (gilts) were primo-vaccinated 6 and 3 weeks 
before insemination with a 2  mL intramuscular injec-
tion of an inactivated trivalent H1avN1, H1huN2, H3N2 
vaccine (Respiporc Flu®3, formerly GRIPOVAC®3, IDT 
Biologika GmbH, Dessau-Rosslau, Germany) containing 
antigens representative of three enzootic lineages circu-
lating in Europe [10, 11], followed by three boosters 6, 
3 and 2 weeks before farrowing in order to induce high 
antibody levels in the colostrum.
Thirty-six SPF piglets born to vaccinated SPF gilts 
and fed as far as possible by their own dam, constituted 
a group of piglets with swIAV-specific MDAs (MDA+ 
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group), whereas 36 SPF piglets without MDAs (MDA− 
group), born to unvaccinated SPF gilts, were also used.
Experimental design
Thirty-three piglets from each group (MDA+ and 
MDA−) were assigned to 6 independent rooms (2 pens 
per room) according to their serological status (Figure 1). 
Pen composition was evenly balanced according to the 
weight, sex, dam’s origin and the 5-week-old MDA level. 
In each room, 2 seeder piglets were inoculated intratra-
cheally with 106 EID50 (Embryonic 50% Infectious Dose) 
of a European avian-like swine H1N1 (H1avN1) virus (A/
Sw/Côtes d’Armor/0388/09 strain) from the same genetic 
lineage than the H1avN1 vaccine antigen [10, 11, 29], in 
a total volume of 5 mL, at 35 days of age (D0). Piglets to 
be inoculated were gathered in a different room for the 
inoculation and placed in contact with the other animals 
1 day post-inoculation (dpi 1). In each room (3 replicates 
per group), the 2 seeder piglets were placed in contact 
with 4 piglets in the same pen to assess transmission 
through direct contact and 5 piglets were placed in the 
second pen, 30 cm apart, to assess transmission through 
indirect contact (no pig-to-pig contact allowed).
The remaining piglets from each group (3 MDA+ and 
3 MDA− piglets) were placed in 2 different pens in a sev-
enth independent room (Figure 1) and were mock-inocu-
lated [5 mL of minimum essential medium (Eagle, Lonza, 
Belgium)], constituting the negative control groups. The 
experiment ended on dpi 28, corresponding to 63 days of 
age.
The experiment protocol was approved by the Anses/
ENVA/UPEC Ethical Committee on animal experiments 
(agreement #16 with the National committee for Ethics 
in animal experimentation) and authorized by the French 
Ministry for Research under the legal notice 11/03/14-17.
Sampling and laboratory analyses
Biosecurity measures
Strict measures were taken to prevent viral transmis-
sion through human or fomite contacts. Samples were 
taken firstly in the indirect-contact pen and secondly in 
the pen that housed inoculated and direct-contact pig-
lets. Inside the latter, direct-contact piglets were sampled 
before inoculated piglets. In each room, clothing and 
footwear were cleaned and gloves changed after each pen 
visit. Clothing and footwear were changed between each 
room and a shower was taken when leaving and entering 
another room. Individual sampling materials were used 
for each piglet.
swIAV serological analyses
Blood samples were collected by jugular vein puncture, 
using evacuated tubes without an additive (Vacuette, 
Dutscher SAS, Brumath, France). Vaccinated gilts were 
sampled 4 and 1 week before, and 3 weeks after, insemi-
nation. They were also bled at 7, 5, 3 and 2 weeks before 
farrowing and 1, 2, 6, 15 and 20 weeks post-farrowing to 
verify that high antibody levels would be obtained at far-
rowing and to further monitor serological titres in sera on 
a long-term basis. In piglets, blood samples were taken 
at farrowing (34  days before inoculation), 3  days before 
the trial began and twice a week after infection (dpi 4, 7, 
11, 14, 18, 21 and 25). Sera (576 samples) were obtained 
by blood centrifugation for 5 min at 3500 × g and stored 
at −20 °C. Post-vaccination antibodies, MDAs and post-
infection antibodies directed against swIAVs (NP and M 
antigens) were quantified in sera using LSIVet™ Porcine 
influenza—Serum ELISA Kit (VETSIV/I, Life Technolo-
gies, Courtabœuf, France). Antibody levels are expressed 
in % IRPC (Relative Index Percent). Although the positive 
threshold is defined by the manufacturer as 20% IRPC in 
field conditions, we determined the positive threshold 
corresponding to our experimental conditions in SPF 
pigs considering the results from SPF MDA− piglets. 
Moreover, cross-classified results with HI tests on nega-
tive and a range of positive serums were used to define 
categories of piglets being negative, or with low and high 
antibody titres. Post-vaccination antibodies in gilts were 
also titrated in hemagglutination inhibition (HI) tests 
using virus strains representative for H1avN1, H1huN2 
and H3N2 lineages as antigens, following the procedure 
described in [15].
swIAV detection and quantification in nasal secretions
To assess viral shedding, nasal swabs (MW951 sent, Viro-
cult®, Corsham, UK) were taken from seeders and direct 
and indirect contacts from both MDA+ and MDA− 
groups on a daily basis from D0 to dpi 14, and every 
2  days thereafter until dpi 28. In control groups, nasal 
swabs were taken once a week throughout the duration of 
the experiment. All nasal swab supernatants (1317 sam-
ples) were stored at −70 °C until virological analysis.
For swIAV detection, RNA were isolated using Nucle-
oSpin® 8 Virus (Macherey Nagel, Hoerdt, France) and 
submitted in quadruplicates to high-throughput analy-
ses on LightCycler® 1536 Real-Time PCR Instrument 
(Roche). Briefly, real-time M gene RT-PCR [30] was 
conducted in duplex with the amplification of porcine 
β-actin gene [31] as an internal control. Each replicate 
comprised 1  µL RNA extract, 0.4  µM and 0.8  µM of M 
gene forward and reverse primers, respectively, 0.6 µM of 
β-actin gene primers and 0.25 µM of probes in a final vol-
ume of 2 µL. Reverse transcription (RT) was performed 
for 30  min at 45  °C using GoScript™ RT Mix M700A 
(Promega) at a 2× final concentration. After an initial 
activating step of 2  min at 95  °C, PCRs were run using 










Inoculated piglets born to non-vaccinated s 
Contact piglets born to non-vaccinated s
Negave control piglets born to non-vaccinated s 
Inoculated piglets born to vaccinated s 
Contact piglets born to vaccinated s
Negave control piglets born to vaccinated s 
Figure 1 Description of the experimental design. Representation of the contact structure of the experiment (inoculated and direct-contact 
piglets in the pen on the left side of each room; indirect-contact piglets on the right side) for both MDA+ group (piglets having maternally-derived 
antibodies (MDAs); first column, rooms B1, B2 and B3) and MDA− group (piglets without MDAs; second column, rooms F1, F2 and F3). Control 
piglets (MDA+ and MDA−) are in room C1.
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Real Time ready DNA Probes Master Mix (Roche) at a 
1× final concentration. Fluorescence data were collected 
at the end of each of the 40 cycles of 1 s at 95 °C and 30 s 
at 60 °C. One sample was interpreted positive as soon as 
M gene was amplified in one replicate out of four.
The swIAV genome was then quantified in selected 
samples from contact piglets. Five µL of RNA extracts 
were tested using same primers and probes as above and 
the GoTaq® Probe 1-Step RT-qPCR System (Promega, 
Madison, USA) in a total volume of 25 µL (M and β-actin 
probes at 0.5  µM and 0.3  µM, respectively). RT-PCR 
(45 °C for 30 s, 95 °C for 2 min, followed by 40 cycles of 
95  °C for 15 s and 60  °C for 1 min) was performed in a 
MX3005P qPCR System (Agilent Technologies, Santa 
Clara, USA). Serial dilutions of standardized M and 
β-actin mRNAs were tested similarly to generate stand-
ard curves. The swIAV genome amount was expressed as 
the M gene copy number per 104 copies of β-actin gene.
Virus detection in aerosols
To detect swIAV genome in aerosols, air samples were 
taken in each experimental room housing infected piglets 
3 times a week between D-3 and dpi 25 using Coriolis®μ 
microbioal air sampler (Bertin Technologies, St-Quentin 
en Yvelines, France) (300 L/min, 10 min/room, in 15 mL 
of 0.005% Triton solution). Collected air samples were 
concentrated using Amicon® Ultra-15 30 K centrifugal fil-
ter devices (Merck Millipore Ltd, Ireland). After centrifu-
gation for 30  min at 3900 × g, RNA were purified from 
150  µL eluate using RNeasy Mini Kit© (Qiagen GmbH, 
Hilden, Germany) and 5 µL RNA extract were tested by 
real-time M gene RT-PCR (LSI VetMAX™ Swine Influ-
enza A-A/H1N1/2009 included, Life Technologies, Lis-
sieu, France) [32]. The conversely cycle threshold 45–Cq 
values were used to represent a semi-quantitative ten-
dency of the evolution of swIAV genomic load in aerosols.
Statistical analysis and models
Duration of the persistence of maternally‑derived antibodies
A nonlinear mixed-effects model (NLME) based on sero-
logical data was used to estimate individual parameters 
governing antibody kinetics in MDA+ piglets. The decay 
of antibody titres was assumed to follow an exponential 
decrease governed by equation dA/dt = −rA. Thus, the 
MDA levels depend on the initial level of MDAs A0 and 
MDA decay rate r. The model describing the serological 
titre of the individual i at observation time tj (with a con-
stant residual error model) is given by:
where A0(i) and ri are the individual parameters and ɛij 




−ritj + aεij ,
parameters were assumed to be log-normally distributed, 
as described in Snoeck et al. [33]. The model for individ-
ual parameters is given by:
where i denotes the individual, rpop and Apop0    the median 
decay rate and initial serological level of the global popu-
lation. Vectors ηA(i) and ηr(i) are vectors of random effects 
assumed to be independent centred Gaussian vectors 
with variance ΩA and Ωr representing inter-individual 
variability [34]. Population parameters were estimated 
using MLE by the SAEM algorithm for the hierarchical 
nonlinear mixed-effects model analysis with Monolix 
software [35, 36].
Individual parameters were used for long–term projec-
tions of individual profiles. A parametric survival analysis 
with a gamma distribution of survival times was finally 
carried out to estimate the duration of MDA persistence.
Modelling within‑host infectious process using viral genome 
loads quantified in nasal swabs from contact piglets
A model of within-host influenza dynamics [37] was used 
to compare shedding dynamics in MDA+ and MDA− con-
tact piglets based on the target-cell-limited TIV model 
(susceptible Target cells, productively Infected cells, free 
Viral particles assessed by viral genome load; [38–40]):
This set of differential equations describes the dynam-
ics of susceptible target cells T becoming infected (I) at 
a constant rate α by contact with free infectious viral 
particles V. Infected cells I produce virus at an average 
rate p per cell until their death at a rate δ per day, giv-
ing an average lifespan for I cells of 1/δ. Free viral par-
ticles disappear at a clearance rate c per day. The effects 
of the immune response are implicitly included in the δ 
and c rates. Parameters governing the differential equa-
tions of the model were individually estimated for each 
group (MDA+/MDA−) by least squares minimisation 
using a quasi-Newton algorithm. Based on individual 
parameters, differences in shedding pattern according to 
the initial serological status of the animals were assessed 
by comparing the peak of viral shedding and the global 
amount of virus shed throughout the shedding period 

















= αTV − δI
dV
dt
= pI − cV .
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Estimation of between‑host transmission parameters
The virus transmission process was described by an MSEIR 
model [41] (Piglets having MDAs—Susceptible—Exposed 
(i.e. latently infected)—Infectious—Removed), incorporat-
ing (i) two different transmission routes according to the 
contact structure between individuals (direct contact in the 
same pen or indirect airborne transmission) and (ii) differ-
ent levels of susceptibility to infection to account for the 
initial serological status of the piglets (MDA+ or MDA−). 
A piglet was considered infectious from the first to the last 
positive RT-PCR nasal swab and the duration of the shed-
ding period was estimated by parametric survival analysis. 
In the event of a negative RT-PCR result between two posi-
tive results, the piglet was assumed to be infectious at that 
time. Combining the results of previous experiments [7] 
and field observations [15], a latency duration of between 
0.5 and 1.5 days was selected for contact piglets. Thus, as 
the exact time contact piglets became infected was not 
observed due to the latency stage, the interval in which 
piglets became infected was determined by subtracting 1.5 
and 0.5 days (the latency period) from the first positive RT-
PCR (i1) giving an infection interval [e1, e2] for each con-
tact-infected piglet calculated as [i1—1.5, i1—0.5] [42].
Two transmission routes were considered in this experi-
ment, parameterised by the corresponding transmis-
sion rate parameter: (i) direct transmission β modelling 
pig-to-pig contacts between pen-mates and (ii) airborne 
transmission βair affecting all animals within a room. 
Those transmission rates were weighted by a susceptibil-
ity-to-infection factor σ which accounts for a different 
susceptibility to infection for piglets in presence of MDAs 
compared to MDA− piglets (σ = 1 in this latter case). The 
prevalence of shedding piglets per pen and per room was 
calculated for each time interval T (duration Δt). Assuming 
that all the shedding animals contribute to infection pres-
sure by the airborne route, the within-room prevalence 
was considered as an approximation of the virus quantity 
in the surrounding air. The transmission rates (β and βair) 
represent the number of newly-infected piglets due to one 
infectious piglet per day. The global force of infection λk 
combines the two viral transmission routes. Thus, a piglet 
k can become infected by direct contact with an infectious 
pen-mate (transmission rate parameter β) or by contact 
with a contaminated aerosol (parameter βair), weighted by 
the susceptibility factor σ according to its serological sta-
tus. The global force of infection λk for a piglet k located 
in pen p and room r is thus calculated at time t as follows:
with Ip(t) and Ir(t) the (time-dependent) number of infec-
tious piglets in pen p or room r at time t; Np and Nr the 







The probability for each piglet k to avoid infection 
when submitted to the global force of infection λk up to 
time e1 is e−
∫ e1,k
0 σkk (t)dt, with σk being the susceptibility 
factor of individual k:  σk =
{
1 if MDA− piglet
σ if MDA+ piglet
. The 
probability of becoming infected during time interval 





The product of all contact-infected piglets gives the full 
likelihood function L:
The transmission rates (β and βair) and the susceptibil-
ity factor (σ) were then estimated by likelihood maximi-
sation [43]; confidence intervals were derived from the 
likelihood profile.
The impact of the contact structure and the initial sero-
logical status on (i) the shedding start time and (ii) shed-
ding duration was assessed using a semi-parametric Cox 
model.
Results
Serological profiles of gilts and piglets and duration 
of persistence of maternally‑derived antibodies
In gilts, HI tests showed that the primo-vaccination (two 
injections at week 2 and week 5) led to an increase in 
titres of HA antibodies directed against the three vac-
cine antigens, i.e. H1avN1, H1huN2 and H3N2 viruses 
(see Additional file 1). Then, HI titres decreased until the 
first booster (week 16). The second and the third boost-
ers did not induce any significant new increase in anti-
body titres but would help maintaining serological titres 
until farrowing at week 23 (21 weeks after primo-vacci-
nation). Serological analyses using an ELISA targeting all 
M and NP antibodies displayed the same kinetic pattern 
for post-vaccination antibodies. Antibodies levels varied 
from 18 to 28% IRPC at insemination time, 3 weeks after 
primo-vaccination. Two weeks after the first booster, 
the levels increased up to 80–90% IRPC, and remained 
around 70% IRPC after the last boosters until farrowing.
Considering the similar results obtained in gilts with 
both methods and the continuous data provided by the 
ELISA, this assay was used to analyse the serological 
profiles of the piglets and estimate the duration of MDA 
persistence. It appeared that the initial antibody levels in 
MDA+ piglets ranged from −6 to 79% IRPC and a limited 
but non-negligible proportion of piglets were character-
ized by serological profiles resembling those of MDA− 
piglets, with a slight increase in antibody levels after 
infection (Figure  2). In addition, all those piglets with 
low initial ELISA titres had HI titres below 1:10 (data 
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within the MDA+ group, one for piglets with high ini-
tial antibody levels (n = 26) and the other for low levels 
(n = 7). These two groups are further denoted as MDAH+ 
and MDAL+ respectively. MDAL+ piglets were character-
ised by a slight serological response after infection very 
close to MDA− piglet profiles (n  =  33) (Figure  2). In 
the light of the serological response observed in MDAL+ 
piglets, the transition from MDAH+ to MDAL+ status was 
selected to be at 10% IRPC. According to this threshold, 
the mean age of transition (i.e. duration of MDA persis-
tence) estimated by the parametric survival model was 
71.3 days [95% confidence interval 52.8–92.1].
Viral shedding and estimation of transmission parameters
Viral shedding
No viral shedding was detected in the control piglets at 
any time during the experiment (data not shown). All 
inoculated piglets began to shed the H1N1 virus between 
dpi 2 and dpi 4. A similar behaviour was observed in each 
room: the inoculated piglets began to shed virus first, fol-
lowed by the direct and indirect contacts (Figure  3). In 
each room, one or two indirect-contact piglets became 
infected simultaneously in the second pen through air-
borne transmission. In the rooms housing MDA+ piglets, 
the first direct- and indirect-contact piglets to become 
infected were MDAL+ piglets.
All contact piglets were infected during the experiment 
with a variable delay according to the contact structure 
and immune status (MDA+ or MDA−). The complete 
infection of all the piglets within the room was longer in 
MDA+ than in MDA− group. MDA− and MDAL+ contact 
piglets began to shed the virus more rapidly than MDAH+ 
piglets (Hazard Ratio = 3.36 [1.85–6.09]; p < 0.05). How-
ever, as the individual average duration of shedding was 
not influenced by the presence of MDAs (HR = 1.39 
[0.84–2.30]; p = 0.2), the overall average duration of 
shedding was 6.1 days [5.9–6.4].
Within‑host infectious process parameters
Based on virus detection in nasal secretions, the swIAV 
genome was quantified in samples from all (MDA+ and 
MDA−) direct-contact piglets obtained from dpi 5 to dpi 
9, as well as in samples from MDA+ and MDA− indirect-

































Figure 2 Swine influenza A serological profiles observed in the different piglet groups. Serological profiles (ELISA LSI, boxplot) of piglets 
having high initial antibody levels and showing continuous antibody decay without serological response after infection (MDAH
+, dark blue), piglets 
having low initial antibody levels and showing moderate serological response after infection (MDAL
+, light blue) and piglets without maternally-
derived antibodies and showing a marked serological response after infection (MDA−, red).
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to dpi 11 respectively. MDA+ and MDA− contact piglets 
exhibited similar individual shedding profiles with a peak 
on day 2 since infection followed by a rapid decay up to 
9 days. The average population profiles are shown in Fig-
ures  4A, B (black lines), along with individual data for 
MDA+ and MDA− piglets (dots in Figures 4A, B respec-
tively). The mean population parameters and variation 
ranges from the ODE model are described in Additional 
file 2. The characteristics of the virological profiles (peak 
and global viral shedding) were investigated in the three 
subgroups previously distinguished using serological 
data (Figures  4C, D). A slight but significant difference 
was found between the shedding peaks in MDAH+ and in 
MDA− contact piglets, with a difference of 0.7 log10 in 
the average number of viral genome particles between 
the two groups (4.6 and 5.3 in MDAH+ and in MDA− pig-
lets respectively; p  <  0.001). The peak in MDAL+ piglets 
was in the same range as the MDA− group (p =  0.08). 
No significant difference was found between the aver-
age global amount of virus shed by the three subpopula-
tions (22.5, 19.8 and 22.2 for AUC in MDAH+, MDAL+ and 
MDA− groups respectively; p = 0.18).
Between‑host transmission parameters
Considering the above mentioned diversity in serologi-
cal profiles, three models weighting the susceptibility to 
infection according to the MDA levels of the piglets were 
tested for transmission parameter estimation: (i) three 
factors of susceptibility were estimated accounting for 
serological profile diversity (i.e. high level, low level, and 
absence of MDAs) (σH ≠ σL, model 1); (ii) owing to the 
limited number of MDAL+ piglets (n = 7) and the similar-
ity with MDA− piglets of their post-infectious serological 
profile, the same susceptibility to infection were assumed 
for these both groups (σL  =  1, model 2); (iii) a unique 
factor of susceptibility was estimated for all MDA+ pig-
lets, the serological profile diversity between MDAH+ 
and MDAL+ piglets was not taking into account (σH = σL, 
model 3). The parameters estimated for each model as 
well as the criteria of model quality are summarized in 
Table 1.
The BIC (Bayesian Information Criteria) high-
lighted the relevance of estimating the same suscep-
tibility to infection for MDAL+ and MDA− piglets 
(BICmodel-2  =  116.2). Under experimental conditions, 
a fully-susceptible piglet (MDA− or MDAL+ piglet) was 
able to infect 2.43 piglets per day by direct contact (β 
= 2.43 [1.09–4.23]), which was almost threefold higher 
than MDAH+ piglets (σH = 0.39 [0.21–0.70], σHβ = 0.95 
[0.23–2.96]). Within a room, 1.41 piglets became infected 
via the air per day (airborne transmission rate βair = 1.41 
[0.64–2.63]).
A combination of the estimated transmission rates and 
a shedding period of 6.1 days [5.9–6.4] was used to esti-
mate reproduction numbers: MDAH+ piglets were infected 
despite the presence of MDAs and could transmit the 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 18 1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 18























































Figure 3 Individual virological results. Detection of the influenza A virus genome in nasal secretions of piglets with (first column, rooms B1, B2 
and B3) or without passive immunity (second column, rooms F1, F2 and F3), inoculated or in contact (direct or indirect). Grey-tinted squares match 
positive M gene RT-PCR results (MDAH
+ in dark grey, MDAL
+ and MDA− in light grey).
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virus on average to 5.8 piglets [1.4–18.9] during their 
entire shedding period whereas a fully-susceptible piglet 
could infect 14.8 [6.4–27.1] piglets during the same time 
(Table 2).
No difference was observed between MDA+ and 
MDA− piglet groups as regards the course of the esti-
mated swIAV genome load in air samples. In each room, 
the virus genome load peaked at dpi 9, after which a sig-
nificant amount of virus genome being detected in the 
air 13 days after the last shedding piglets (Figure 5). Con-
sidering a 1-day latency period, the first piglets became 
infected in the indirect-contact pen on dpi 5 and dpi 3 
in the MDA+ and the MDA− groups respectively, when 
there was a substantial amount of virus genome in the air.
Discussion
Understanding the epidemiological processes responsible 
for endemic swIAV persistence within pig herds requires 
a quantitative approach to viral transmission parameters 
within a pig population. Data from field studies have 














































































Figure 4 Shedding profiles of contact piglets and comparison between groups. Average population profiles of viral shedding in MDA+(A) 
and MDA−(B) direct- and indirect-contact piglets; distributions of the viral shedding peak (C) and the global amount of viral shedding (AUC, D) in 
MDAH
+, MDAL
+ and MDA− direct- and indirect-contact piglets.
Table 1 Estimation of the transmission parameters [95  % 
Confidence Interval] for MDAH
+ (n = 26), MDAL+ (n = 7) and 
MDA−(n = 33) piglets
Overall population estimate applying to MDAH
+ and MDAL
+ piglets; BIC: Bayesian 
Information Criteria
With β being the direct transmission rate, βair the airborne transmission rate, 
σH the susceptibility factor for MDAH
+ piglets and σL the susceptibility factor for 
MDAL
+ piglets.
Model 1: different susceptibility factors for MDAH
+, MDAL
+ and MDA− piglets (σH ≠ σL 
and σH,L < 1).
Model 2: same susceptibility factor for MDAL
+ and MDA− piglets (σL = 1 and σH < 1).
Model 3: same susceptibility factor for MDAH
+ and MDAL
+ piglets (σH = σL et 
σH,L < 1).
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suggested an interaction between the immune status of 
animals at the time of infection and viral spread between 
batches, leading to persistence of infection on farms [15, 
16]. The transmission experiment herein described was 
designed to estimate transmission parameters in con-
trolled conditions and compare these estimates for two 
populations differing only by their maternally derived 
immune status. Such references in terms of quantita-
tive estimates of transmission parameters are required 
to assess the consequences of swIAV infections in 
young animals still having MDAs, and evaluate assump-
tions related to factors increasing the likelihood of viral 
persistence within a population. Two complementary 
approaches were thus developed, considering on the one 
hand within-host models to analyse individual serological 
and virological data, and on the other, between-host 
models to evaluate the transmission of swIAVs in a struc-
tured population.
In this study, two different viral transmission routes 
were considered within the same room: (i) direct trans-
mission, which can only occur between pen-mates 
through pig-to-pig contact and (ii) indirect airborne 
transmission, which can occur between all the pigs in 
a room, including pen-mates. Although carried out in 
experimental conditions, the design was developed to 
represent a contact structure close to field condition, 
accounting for transmission between pen-mates and 
neighbouring pens.
The individual profiles of maternal antibody decay 
in piglets born to vaccinated gilts led to an estimated 
Table 2 Estimation of the reproduction numbers R0 for MDA
+and MDA−piglets using the best model (model 2)
a  Overall population estimate applying to both groups.
Shedding period (days) Direct transmission rate β (days−1) Susceptibility
factor σ
R0
MDA+ piglets 6.1 [5.9–6.4]a 2.43 [1.09–4.23]a 0.39 [0.21–0.70] 14.8 [6.4–27.1]
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Figure 5 Viral genome loads in aerosols. Deduced from M gene RT-PCR analyses (45—Cq value) performed on air samples taken in each room 
(rooms B1, B2 and B3 correspond to rooms housing piglets with maternally-derived antibodies (MDAs); rooms F1, F2 and F3 to piglets without 
MDAs) during the animal experiment.
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71.3  days of MDA persistence [52.8 – 92.1]. A transi-
tion to a “more-susceptible-to-infection” status around 
10  weeks seems realistic for SPF piglets born to multi-
vaccinated gilts. Indeed, in field conditions, MDAs were 
shown to persist for 11 weeks on average [15]. In experi-
mental conditions, piglets born to conventional vacci-
nated sows showed MDA persistence ranging from 8 to 
13 weeks of age [44, 45]. Like in previous studies, the cur-
rent experiment revealed heterogeneity between individ-
ual profiles. This could be linked to dam antibody levels 
and/or uneven colostrum intake by piglets. MDA con-
centration in the colostrum has been shown to decline 
rapidly in the first 24  h [46]. An appropriate colostrum 
intake in the first hours of life is known to be crucial for 
supplying newborn piglets with high levels of MDAs. In 
our study, 7 piglets born to an aggressive gilt had to be 
cross-fostered. Born a few hours after the others, these 
piglets probably had limited access to rich colostrum 
[46]. Four of the 7 cross-fostered piglets were incidentally 
in the MDAL+-piglet group.
The observed heterogeneity in serological status at time 
of infection was strongly associated with the pattern of 
post-infectious serological response. As described pre-
viously [15, 25], no detectable serological response after 
infection was observed in MDAH+ piglets, while piglets 
with low antibody levels at the time of infection (MDAL+) 
showed a moderate serological response. The transmis-
sion characteristics of MDAL+ piglets were also signifi-
cantly different from those of MDAH+ piglets, contributing 
more to the transmission process. Differences in the viral 
kinetics of these two groups were also highlighted by a 
within-host modelling approach which revealed a higher 
shedding peak in MDAL+ piglets than in MDAH+ animals. 
However, the global within-host infectious process and 
the amount of virus genome shed by infected individu-
als were not found to differ significantly in these two 
sub-populations. It suggests that the presence of mater-
nally-derived antibodies did not strongly affect the indi-
vidual shedding pattern once an animal was infected. 
Therefore, differences between MDAH+ and MDAL+ piglets 
are more likely related to a higher susceptibility to infec-
tion of piglets having low antibody levels after weaning. 
Consistent with this assumption, MDAL+ piglets were the 
first to be infected in the room housing piglets born to 
vaccinated dams. It therefore reinforces the relevance of 
accounting for heterogeneity rather than considering all 
piglets born to vaccinated dams as a whole. In contrast, 
shedding patterns and serological responses observed 
in MDAL+ piglets are similar to those of MDA− piglets, 
emphasising the advantage in considering the same sus-
ceptibility factor for these two subgroups.
The estimates in MDA+ (0.95 [0.23–2.96]) and in 
MDA- piglets (2.43 [1.09–4.23]) agree with the literature 
[15, 19, 26]. Recently, Allerson et  al. [26] estimated the 
transmission rates of a H1N1 strain of American lineage 
at 1.74 [1.18–2.46] and 2.18 [1.47–3.10] in conventional 
piglets born to vaccinated (distinct lineage between the 
vaccine and the challenge strain) and non-vaccinated 
sows, respectively. A higher homology between the vacci-
nal and the inoculated strains (HA genes belonging to the 
same genetic lineage in our experiment versus different 
clades in Allerson’s study) could have induced a higher 
protection in our experimental conditions. Also, we can 
not exclude differences in terms of transmission related 
to the status of the animals (SPF piglets in our experiment 
versus conventional piglets in Allerson’s study) and/or 
the design of the experiment, which in our case consid-
ers both direct and indirect transmission. The European 
avian-like swine H1N1 (H1avN1) virus used in the pre-
sent experiment is the most frequently detected swIAV 
in Europe [10] but it would be interesting to reproduce 
the present experiment with swIAVs from other enzootic 
lineages included in the vaccine to compare transmission 
parameters.
Inoculated piglets began viral shedding between dpi 2 
and dpi 4. Previous data from published studies corrobo-
rate these results [7, 19]. Intratracheal inoculation poten-
tially differs from a natural infection process by aerosols 
which could be faster. In field conditions, a latency period 
of 0.5 to 1.5  days has been estimated [15]. The delay 
between the first viral shedding in inoculated and contact 
piglets was sometimes within one day in our experiment. 
A latency period varying from 0.5 to 1.5 days was there-
fore selected to account for all these components.
To our knowledge, this is the first time that the air-
borne transmission rate of swIAV has been quantified. 
Although several studies have investigated this topic, 
focussing either on the relationship between the number 
of infected pigs and viral presence in the air [47] or the 
quantification of the virus in the air [48], no transmission 
parameters have been estimated to date. The airborne 
virus transmission rate estimated in our study revealed 
that 1.41 piglets became infected per day via the air and 
at a lower rate in MDA+ piglets because of reduced sus-
ceptibility. Each indirect-contact pen became infected 
in all the rooms, demonstrating the need to account for 
the airborne component in the infection process so as 
to accurately understand the spread and persistence of 
swine flu. Indeed, compared to field conditions with 
several 100 piglets per room, a limited number of infec-
tious piglets were required to infect room-mates by the 
airborne route in this experimental study. The venti-
lation system in the ANSES experimental facilities is 
also more efficient than on conventional pig farms, as a 
smaller volume of air is renewed more frequently. This 
parameter could have induced an underestimation of 
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airborne transmission compared to field conditions. 
The swIAV genome was furthermore detected in the air 
of the room up to 13 days after the last shedding piglet 
was detected, highlighting the persistence of viral RNA 
in aerosols and the importance of considering this issue 
in endemic swIAV within-herd management. Airborne 
swIAV detection has been also reported previously in 
the environment of infected MDA+ pigs [49]. From our 
results, the observed increase in the deduced amount of 
virus genome in the air and individual viral shedding cor-
responds also to the point where the incidence of infec-
tion is the higher within the pen.
The duration of the shedding period estimated in the 
present study is longer than previously published experi-
mental data [26] but shorter than field-based estima-
tions [15]. The differences could be linked to the status 
of the piglets (SPF piglets in the present case) as well as 
the assessment and characteristics of influenza outbreaks 
described in field conditions. In the latter case, the length 
of the shedding period was also estimated on the basis 
of M gene RT-PCR results which do not discriminate 
between subtypes, but characterization of the isolates 
showed a frequent observation of the co-circulation of 
2 subtypes slightly delayed over time, which artificially 
increased the estimated shedding period based on M 
gene RT-PCR results.
Similarly to Lange et  al. [50], a concise global shed-
ding period was observed at group scale in MDA− con-
tact piglets. Although displaying maternal immunity 
against the H1N1 subtype, piglets with high initial anti-
body levels (MDAH+) revealed a high potential for viral 
spread. The reproduction number (i.e. smaller than that 
for MDA− piglets but significantly higher than 1) led to 
an extended total duration of the infectious process at 
the scale of a maternally-immune pig population. Trans-
posed to field conditions, this extended infectious period 
could foster within-herd viral persistence through the 
permanent exposure of incoming susceptible piglets 
to shedding animals from other batches [15, 16]. This 
assumption would have to be evaluated in a simulation 
study. Likewise, a longer period with shedding piglets 
at herd level increases the probability of concomitant 
multiple-strain circulation and thus generation of reas-
sortant viruses [15].
In this experiment, piglets were inoculated at 35 days of 
age, corresponding to what has been frequently observed 
on pig farms affected by endemic influenza persistence 
when it strikes piglets after weaning [15]. At that age, pig-
lets still have high levels of MDAs, so transmission was 
evaluated in a maximised situation. According to our 
estimate of the duration of MDA persistence, the inter-
val when transmission is expected to be impacted by the 
presence of MDAs is quite large (up to 10  weeks). This 
would be consistent with current field observations, 
which suggest a high prevalence of endemic swIAV situa-
tions in farrow-to-finish farms. It also raises the question 
of the effect of regular sow herd vaccination before far-
rowing in this context, which would boost antibody pro-
duction in sows and increase the levels of MDAs received 
by piglets through colostrum. Indeed, based on the sero-
logical results of the gilts, we can see that the primo-
vaccination induced a moderate serological response, 
while the first booster carried out 13  weeks later (i.e. a 
few weeks before farrowing) induced a dramatic increase 
in antibody levels which were still detectable  4  months 
after the last booster (around the next expected farrow-
ing time).
The spread of influenza virus is modified by piglets’ 
maternally-derived immune status at the time of infec-
tion and inter-piglet contact structure. Although the 
presence of MDAs in weaned piglets significantly reduces 
swIAV transmission, the reproduction number is signifi-
cantly higher than 1, highlighting the limited protection 
conferred by MDAs against the spread of influenza virus. 
Adverse effects are observed: the dissemination process 
is slower compared to piglets without passive immunity, 
fostering the presence of shedding animals over a longer 
period at population scale, which could enhance swine 
flu within-herd persistence. Thus, it appears crucial to 
account for the maternally-derived immune status of the 
animals and the contact structure (direct or by airborne 
route) between weaned piglets in order to identify con-
trol measures designed to prevent endemic persistence 
of swIAV infections in pig herds. Airborne transmission 
was also identified as a key point, highlighting the need to 
consider infectious aerosols as a major issue possibly par-
ticipating to within-herd swIAV spread and persistence.
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